ADA 2013: Major Players Present Data On Insulins, GLP-1s, SGLT-2s
This article was originally published in The Pink Sheet Daily
Executive Summary
The annual ADA conference will include data from a slew of companies, but analysts are most interested in the presentations from the biopharmas that already dominate the market and are expected to maintain their market share in the long-term.